Takeda Pharmaceutical Co. Ltd. - Gross Profit Margin

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Gross-Profit-Margin" stands at 55.64 percent as of 09/30/2025, the highest value since 09/30/2023.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Gross Profit Margin" stands at 55.64 Percent. This represents an increase of 2.87 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.19 percentage points compared to the value the year prior.
The 1 year change in percentage points is 2.19.
The 3 year change in percentage points is 1.76.

The Serie's long term average value is 53.68 percent. It's latest available value, on 09/30/2025, is 1.97 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is +4.66.
The Serie's change in percentage points from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -0.286.